| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701614 | Journal of Thoracic Oncology | 2017 | 11 Pages |
Abstract
In this large database analysis of PORT for thymic tumors, PORT was associated with longer OS, with the greatest relative benefits observed for stage IIB to III disease and positive margins. In the absence of randomized studies assessing the value of PORT, these data may inform clinical practice.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Matthew W. MD, David A. MD, MsC, PhD, D. Ross MD, PhD, Bernard L. PhD, Tyler P. MD, PhD, David J. MD, MPH, Matthew MD, Brian D. MD, MPH, Laurie E. MD, MBA, Chad G. MD,